» Articles » PMID: 25664038

Imbalances of Th17 and Treg Cells and Their Respective Cytokines in COPD Patients by Disease Stage

Overview
Specialty General Medicine
Date 2015 Feb 10
PMID 25664038
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The typical balance between Th17 and Treg T cell subsets is altered in various autoimmune diseases. Here, inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) (n=32) and stable COPD (n=36) were compared with smokers with normal lung function (n=40, control group). Flow cytometry was used to detect proportions of Th17 and Treg cells in the peripheral blood. ELISA of induced sputum samples was used to detect IL-17 (secreted by Th17 cells) and TGF-β1 (secreted by Treg cells) concentrations. The proportion of Th17 cells in peripheral blood and secreted IL-17 and TGF-β1 levels in sputum were significantly higher in acute exacerbation of COPD patients than in stable COPD and control groups (P < 0.05). Additionally, the proportion of Treg cells was lower than in stable COPD but higher than in controls. Th17 proportions were negatively correlated with Treg proportions in both acute exacerbation and stable COPD patients, and positively correlated with IL-17 levels (P < 0.05). Further, there was a positive correlation between Treg proportion and TGF-β1 levels (P < 0.05). Thus, COPD patients have shifts in the balance of Th17/Treg cells. Acute exacerbation of COPD is shifted toward a pro-inflammatory response, while stable COPD is shifted toward an anti-inflammatory response. This finding may provide a new direction for future clinical treatment of COPD by seeking to repair the disrupted balance in T cells.

Citing Articles

Oral administration of Lactobacillus plantarum expressing aCD11c modulates cellular immunity alleviating inflammatory injury due to Klebsiella pneumoniae infection.

Zeng Y, Li T, Chen X, Fang X, Fang C, Liang X BMC Vet Res. 2024; 20(1):399.

PMID: 39244529 PMC: 11380324. DOI: 10.1186/s12917-024-04248-9.


The Role of Exhaled Breath Condensate in Chronic Inflammatory and Neoplastic Diseases of the Respiratory Tract.

Kita K, Gawinowska M, Chelminska M, Niedoszytko M Int J Mol Sci. 2024; 25(13).

PMID: 39000502 PMC: 11242091. DOI: 10.3390/ijms25137395.


Nanocurcumin modulates Th17 cell responses in moderate and severe COPD patients.

Mardi A, Abdolmohammadi-Vahid S, Sadeghi S, Jafarzadeh S, Abbaspour-Aghdam S, Hazrati A Heliyon. 2024; 10(9):e30025.

PMID: 38737273 PMC: 11088266. DOI: 10.1016/j.heliyon.2024.e30025.


Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?.

Riondino S, Rosenfeld R, Formica V, Morelli C, Parisi G, Torino F Cancers (Basel). 2024; 16(7).

PMID: 38610929 PMC: 11011072. DOI: 10.3390/cancers16071251.


Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries.

Martinez G, Appleton M, Kipp Z, Loria A, Min B, Hinds Jr T Physiol Rev. 2023; 104(1):473-532.

PMID: 37732829 PMC: 11281820. DOI: 10.1152/physrev.00021.2023.


References
1.
Wang H, Peng W, Weng Y, Ying H, Li H, Xia D . Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposure. Int Immunopharmacol. 2012; 14(4):504-12. DOI: 10.1016/j.intimp.2012.09.011. View

2.
Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

3.
Oboki K, Ohno T, Saito H, Nakae S . Th17 and allergy. Allergol Int. 2008; 57(2):121-34. DOI: 10.2332/allergolint.R-07-160. View

4.
Wozakowska-Kaplon B, Bartkowiak R, Grabowska U, Janiszewska G . B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance. Kardiol Pol. 2010; 68(7):781-6. View

5.
Eisenstein E, Williams C . The T(reg)/Th17 cell balance: a new paradigm for autoimmunity. Pediatr Res. 2009; 65(5 Pt 2):26R-31R. DOI: 10.1203/PDR.0b013e31819e76c7. View